From Kerinci to Da Lat: ALKO Empowers Farmers to Break Boundaries and Learn from Vietnam for the Future of Indonesian Coffee
INMOTION Launches the All-New V12S Electric Unicycle, Redefining Intelligent and Free Urban Mobility
COSRX Launches First-Ever Haircare Line with Patented Peptide-132 Technology
FinVolution Group Prices Offering of US$130 Million Convertible Senior Notes
ActiveOps Announced as Official Data Analytics Partner of The British & Irish Lions and the Qatar Airways British & Irish Lions Men's Tour to Aus
Yarbo Announces New Lawn Mower Pro Attachment
Everest Medicines Announces Successful Release of First Clinical Batch of Tumor-Associated Antigen Vaccine EVM14 at Jiashan Manufacturing Site
Galan Lithium Limited: A$20 million Placement to Strategic Partner
Game-Changer for In-Store Customization: WeCreat's Lumos is a Dual-Laser Beast That Engraves 3× Faster, 2× Deeper--and in Color
Yum China launches AI assistant for store managers, a groundbreaking advance in its tech-driven growth strategy
-
So-Young Announces Extension of Plan to Implement ADS Ratio Change
BEIJING, June 20, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it is amending the effective date for the previously announced plan for an ADS ratio change. The Company previously planned to change the ratio of the American depositary shares ("ADSs") to its Class A ordinary shares from thirteen (13) ADSs representing ten (10) Class A ordinary shares to one (1) ADS representing fifteen (15) Class A ordinary shares, with the change originally scheduled to take effect at the open of trading on June 30, 2025 (U.S. Eastern Time). Following further consideration, the Company has decided to take additional time to finalize preparations for the ADS ratio change. An updated timeline will be announced once it becomes available. For the Company's ADS holders, the ADS ratio change will result in an effect equivalent to a proportional reverse ADS split. There will be no change to the Company's Class A ordinary shares. ADS holders of record on the effective date will not be required to take any action in connection with the ADS ratio change. The exchange of then-held (old) ADSs for new ADS will occur automatically with the then-held ADSs being cancelled and new ADSs being issued by the depositary bank. The ADSs will continue to be traded on Nasdaq under the symbol "SY." No fractional new ADSs will be issued in connection with the change in the ADS ratio. Instead, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank and the net cash proceeds from the sale of the fractional ADS entitlements (after deduction of fees, taxes and expenses) will be distributed to the applicable ADS holders by the depositary bank. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the change in the ADS ratio will be equal to or greater than a proportional price based on ADS price before the change. About So-Young International Inc. So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company") is the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments. The Company provides access to aesthetic treatments through its online platform and branded aesthetic centers, offering curated treatment information, facilitating online reservations, delivering high-quality treatments, and developing, producing and distributing optoelectronic medical equipment and injectable products. With its strong brand recognition, digital reach, affordable treatments and efficient supply chain, So-Young is well-positioned to serve its audience over the long term and grow along the medical aesthetic value chain. Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including but not limited to statements about So-Young's beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the Securities and Exchange Commission. All information provided in this press release is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law. For more information, please contact: So-Young Investor RelationsMs. Mona QiaoPhone: +86-10-8790-2012E-mail: ir@soyoung.com Christensen In ChinaMs. Charlie ChiPhone: +86-10-5900-1548E-mail: charlie.chi@christensencomms.com In USMs. Linda BergkampPhone: +1-480-614-3004Email: linda.bergkamp@christensencomms.com
-
APP Group Highlights Commitment to Sustainable Packaging with Foopak at Foodservice Australia 2025
JAKARTA, Indonesia, June 19, 2025 /PRNewswire/ -- Consumer demand is shaping the future of sustainable packaging in Australia, with 51% of consumers saying sustainability is important when making a purchase. This shift is driving companies to adapt packaging strategies to align with consumer values. Answering the current needs, APP Group participated in Foodservice Australia 2025 with Paper Force, their official representative in Australia. A major highlight was Foopak Bio Natura, a key innovation from APP Group. Visitors flocked to Booth E40 at MCEC Melbourne from May 18 to 20 to explore Foopak's innovative solutions that support packaging needs while advancing sustainability goals. Certified by the Australasian Bioplastics Association (ABA), Foopak meets Australian Standards AS 4736 for industrial compostability and AS 5810 for home compostability, setting a new benchmark for environmentally friendly packaging. "Foopak Bio Natura represents the future of sustainable packaging. It shows that businesses no longer have to choose between high performance and environmental responsibility," said Gavin Gunawan, Regional Sales Head Industrial White APP Group for Australia. "At Foodservice Australia 2025, we look forward to building partnerships with businesses that share APP Group's vision for a more sustainable future." Foopak Bio Natura is engineered for a variety of food and beverage applications. Featuring advanced aqueous dispersion coating technology, excellent heat resistance, superior edge wicking protection, and robust barrier properties, delivering high-quality alternatives to traditional plastic-lined packaging. In addition to being compostable, Bio Natura is certified recyclable by Cyclos. Foodservice Australia remains one of the country's premier events for foodservice and hospitality professionals. The 2025 edition featuresmore than 450 exhibitors presenting the latest in food, beverages, equipment, and packaging innovation. It offers an essential platform for discovering trends, industry connections, and learning from leading experts. About APP Group APP is a leading pulp, paper, and forestry company based in Indonesia, supplying high-quality tissue, packaging, and paper to over 150 countries. With operations in Indonesia and China, we prioritize sustainability, ethical practices, and the well-being of our employees, society, and the environment. Our Sustainability Roadmap Vision 2030, aligned with ESG principles, guides our efforts in environmental protection, community support, biodiversity preservation, and carbon neutrality.
-
GirlStyle Unveils Inaugural "GirlStyle NextGen Glowing Awards 2025," Illuminating the Future of Beauty
HONG KONG, June 20, 2025 /PRNewswire/ -- The beauty industry marks a significant milestone! GirlStyle, a leading female lifestyle information platform under PressLogic, proudly announces the resounding success of its inaugural "GirlStyle NextGen Glowing Awards 2025", which concluded on 30 May 2025. This landmark event served to celebrate pioneers in the beauty sector and presented the very first awards dedicated to "Future Beauty Power," revealing boundless possibilities for the next generation of beauty. GirlStyle NextGen Glowing Awards 2025: Illuminating the Future of Beauty The awards ceremony commenced with an inspiring address from Ryan Cheung, Founder & CEO of PressLogic. Ryan shared the remarkable journey of how a Hong Kong start-up blossomed into an ecosystem boasting over 17 million followers. He then elaborated on how GirlStyle's impressive achievements stem from a strategic integration of big data and AI, seamlessly combined with the expertise of their trend-savvy team. His insightful presentation highlighted the analytical foundation underpinning their creative endeavors. Christine Lai , PressLogic's Co-founder and Vice President of Content Strategy, powerfully articulated the profound significance of these awards. Christine emphasized that the "GirlStyle NextGen Glowing Awards" transcend a mere ceremony, they stand as a heartfelt tribute to those who are courageously redefining beauty standards. She affirmed GirlStyle's unwavering commitment to perpetually champion and guide the next generation of beauty innovation. Christine eloquently underscored that beauty is a potent force, manifesting in every narrative, every choice, and every courageous decision, and that the evening was a celebration of every stride taken to illuminate a brighter future. The success of the "GirlStyle NextGen Glowing Awards 2025" was truly a collective endeavor. GirlStyle extends its sincerest gratitude to the 100 next-generation KOLs, their dedicated professional editorial team, and an incredible 2,574 readers whose invaluable participation played a pivotal role in identifying the most innovative brands within the industry. Awarded Brands & Products: Shaping the Future of Beauty A core highlight of the evening was the celebration of those who are truly pushing boundaries and inspiring others. GirlStyle was immensely proud to congratulate all distinguished awarded brands for their unwavering commitment to innovation and unparalleled quality. Their contributions are truly inspiring and are actively shaping the future of beauty. The following brands received prestigious product awards (in no particular order): Brand Awards The Innovative Glow Award： NIVEA - Thiamidol®630 The Rising Star Brand Award： SKINTIFIC The Social Media Star Award： Medicube The ESG Brand of the Year Award： Merz Aesthetics® - XEOMIN® The Glow-Up Essential Product Award The Glow-up Essential Cleansing Product Award： Bioré - Marshmallow Whip Facial Wash The Glow-up Essential Makeup Removal Product Award： APRILSKIN - Carrotene IPMP Hydromelt Cleansing Balm The Glow-up Essential Hydrating Serum Award： d program - Intense Enriching Serum The Glow-up Essential Hydrating Cream Award： Choi Fung - H2O Hydrating Gel The Glow-up Essential Anti-Aging Product Award： CLARINS - Double Serum The Glow-up Essential Anti-Aging Face Cream Award： LANCÔME - Absolue Longevity Cream The Glow-up Essential Facial Oil Award： Guerlain - Abeille Royale YOUTH WATERY OIL SERUM The Glow-up Essential Whitening Serum Award： OLAY - Radiance Advanced Light Perfecting Essence The Glow-up Essential Essence Award： SK-II - PITERA™ Facial Treatment Essence The Glow-up Essential Night Cream Award： La Mer - The NEW Rejuvenating Night Cream The Glow-up Essential Toner Award： fresh - Rose Deep Hydration Toner The Glow-up Essential Acne Soothing Product Award： Soo Beauté - Calamine Spot Off Essence The Glow-up Essential Nourishing Cream Award： Avène - Revitalizing Nourishing Cream The Glow-up Essential Eye Care Product Award： LANCÔME - GÉNIFIQUE Ultimate Dual-Repair Eye Cream The Glow-up Essential Face Mask Award： SK-II - Facial Treatment Mask The Glow-up Essential Sunscreen Award： ANESSA - Perfect UV Sunscreen Skincare Milk SPF50+ PA++++ The Glow-up Essential Primer Award： Clé de Peau Beauté - Correcting Cream Veil The Glow-up Essential Color Corrector Award： SOFINA - Primavista Long Lasting Primer UV50 SPF 50 The Glow-up Essential Long-Lasting Foundation Award： Dior - Dior Forever Cushion The Glow-up Essential Liquid Foundation Award： Estée Lauder - Double Wear Stay-In-Place Foundation SPF 10/PA++ The Glow-up Essential Cushion Foundation Award： Cyber Colors - SPF50+PA++++Real Nude Soft Glow Cushion Foundation The Glow-up Essential Concealer Award： NARS - Radiant Creamy Concealer The Glow-up Essential Pressed Setting Powder Award： MAKE UP FOR EVER - Matte Compact Blurring Foundation The Glow-up Essential Loose Powder Award： Givenchy - Prisme Libre Loose Powder The Glow-up Essential Blusher Award： YSL Beauty - Make Me Blush Bold Blurring Blush The Glow-up Essential Eyeshadow Award： Charlotte Tilbury - Luxury Palette Pillow Talk Dreams The Glow-up Essential Eyeliner Award： KISSME Heroine Make - Smooth Liquid Eyeliner Super Keep The Glow-up Essential Mascara Award： KISSME Heroine Make - Long UP Mascara Super Waterproof The Glow-up Favorite Lip Product Award： CHANEL - ROUGE COCO FLASH The Glow-up Essential Fragrance Award： CHANEL - N°5 The Best Beauty Treatment Center Award： OASIS medical The Glow-up Essential HA Dermal Filler Award： Juvéderm® The Glow-up Essential IncobotulinumtoxinA Injection Award： Merz Aesthetics® - XEOMIN® The Glow-up Essential Shampoo Award： Kérastase - CHRONOLOGISTE Bain Régénérant Shampoo The Glow-up Essential Hair Repairing Product Award： DOVE - Dove Peptide Intensive Repair Nourishing Oil The Glow-up Essential Hair Dye Product Award： CIELO - Hair Color Cream The Glow-up Essential Body Wash Award： DOVE - Self-foaming Body Wash The Glow-up Essential Sensitive Skin Soothing Body Care Award： QV - QV Ceramides Lotion The Glow-up Essential Body Oil Award： CLARINS - Tonic Body Treatment Oil The Glow-up Essential Body Scrub Award： DOVE - Dove Body Scrub The Glow-up Essential Beauty Device Award： Medicube - AGE-R Booster Pro The Glow-up Essential Slimming Enzyme Supplement Award： GLAM.D - Grain Enzyme Line The Glow-up Essential Slimming Probiotic Product Award： PROVEN - SlimtFit Probiotics The NextGen's Favorite Beauty & Fashion Accessory Award： Dior - Le Baume - Toile de Jouy Limited Edition GirlStyle also extends heartfelt congratulations to the esteemed beauty influencers who received "The Social Glow Icon Award." Their exceptional creativity and genuine engagement not only set new trends but also profoundly inspire countless individuals worldwide. The award recipients are (in alphabetical order): The Social Glow Icon Award Amber Tang 鄧卓殷 (IG ID: amber.tcy) Christy Lee (IG ID: c.705) Elva Ni 倪晨曦 (IG ID: misselvani) Grace 陳凱琳 (IG ID: ghlchan) Heiri Jun 全慧利 (IG ID: junheiri) Hilda Chan 陳曉樺 (IG ID: hildas.thyme) Kayan C 蔡嘉欣 (IG ID: kayan.c) Krystal 妳祺 (IG ID: krystal_petrichor) Yanbe Lam 昕比 (IG ID: yyanbe) Kilby 超酸 (IG ID: kilbychan) Shining Together, Leading the New Generation of Beauty The core purpose of the "GirlStyle NextGen Glowing Awards 2025" is to empower beauty and cosmetic brands to collectively champion novel ideas and groundbreaking advancements. GirlStyle extends its sincere appreciation to all participants; it is precisely your invaluable involvement and support that have collectively imbued this award with deeper meaning and radiant brilliance. We eagerly anticipate embarking on this transformative journey with all of you, witnessing the continued growth of the beauty industry, and collectively radiating even greater splendor in the years to come. To mark this special occasion, highlights from the event are now playing on the large outdoor digital screen at Art Piece, behind Times Square in Causeway Bay. Let's continue to shine brighter together! Official News Release Distribution Partner: PR Newswire, a Cision company Please download high-res photos here and full article here. About PressLogic | Empowering Brands Through Social Media, AI, and Data Founded in Hong Kong in 2016, PressLogic is a next-generation Ad-Tech ecosystem group. We specialize in integrating content creation, data analytics, AI technology, and full-funnel marketing strategies. By leveraging technology and data, we precisely drive content value and business conversions, offering brands a one-stop solution. Our operations span across seven major Asian markets, including Singapore, Malaysia, Taiwan, Korea, India, and Shenzhen. Our team comprises over 200 marketing and tech professionals, having established comprehensive production, technology, and analytical capabilities. Our content matrix covers nine vertical media brands, boasting over 17 million followers and exceeding 500 million monthly content reaches, with rapid continuous expansion. Our media brands cover various lifestyle areas, including: Women's Lifestyle & Fashion: GirlStyle, TopBeauty, POPLADY Business, Finance & Management: BusinessFocus Parenting: MamiDaily Healthy Living: UrbanLife Health Travel & Dining: HolidaySmart Pet Culture: PetCity Korean Wave & Trends: Kdaily In 2023, we were honored with the Deloitte Hong Kong Technology Fast (AI Software category) award and successfully admitted into the Hong Kong Science Park's "Elite Programme" (Information and Communications Technology stream). These achievements underscore our deep integration and innovative strength across technology, content, and performance. About GirlStyle GirlStyle is a highly popular online magazine for women's fashion and lifestyle, providing comprehensive and diverse content for modern women. Our coverage spans beauty, fashion, health, lifestyle, and personal well-being. We boast a global social media following of over 6.2 million fans across platforms like Facebook, Instagram, Threads, and LinkedIn, with over 8 million monthly active visitors. These impressive achievements establish GirlStyle as one of the leading female lifestyle information platforms in Hong Kong, Taiwan, Singapore, Malaysia and beyond. Media Contact Philip Chau - Director of Corporate AffairsEmail: philip.chau@presslogic.com Serena Chung - Senior Marketing ExecutiveEmail: serena.chung@presslogic.com
-
Gene Solutions Strengthens China Footprint with Strategic Partnerships in Precision Oncology
BEIJING, June 20, 2025 /PRNewswire/ -- Gene Solutions announces the signing of two strategic Memoranda of Understanding (MOUs) with ZaoDx and Xiong'an MagicBiotech Co., Ltd. These partnerships mark a focused expansion of Gene Solutions' precision oncology efforts into the Chinese market through collaborative technology introduction, research exploration, and localized deployment of its innovative cancer testing platforms. Together, the partnerships reinforce Gene Solutions' long-term commitment to supporting China's healthcare innovation ecosystem with advanced, clinically validated tools for early cancer detection and monitoring. Enabling Early Detection Through Ecosystem Engagement with ZaoDx Gene Solutions and ZaoDx have formed a strategic business alliance to jointly explore the introduction, promotion, and responsible commercialization of advanced early cancer screening technologies in China. Dr. Nguyen Hoai Nghia – Co-founder and CEO of Gene Solutions (left) and Dr. Chen Zanquan – CEO of ZaoDx (right) hand over signed MOU This partnership will focus on: Localized introduction of Gene Solutions' flagship technologies, including the SPOT-MAS multi-cancer early detection (MCED) platform. Joint brand-building and public engagement efforts, aiming to raise awareness of early detection through co-hosted seminars, exhibitions, and community education programs. Medical research ecosystem collaboration, leveraging ZaoDx's strong local presence and relationships with academic institutions, clinical experts, and healthcare stakeholders to support evidence-based application and trust-building across the industry. CEO of ZaoDx Dr. Chen Zanquan stated: "Cancer is a challenge faced globally, and early detection is crucial for cure. ZAODX is pleased to collaborate with Gene Solutions to advance the conversion and accessibility of innovative cancer screening and diagnosis technologies. I believe our joint efforts will bring tangible benefits to millions of families." "Our collaboration with ZaoDx reflects a shared commitment to bringing global innovation into meaningful local impact," said Jiang Hao, Business Development Manager at Gene Solutions. "By working alongside respected research-driven partners, we can responsibly introduce early detection technology to more patients and providers across the country." Advancing Research Collaboration in Northern China alongside MagicBiotech Gene Solutions and Xiong'an MagicBiotech have signed an MOU to jointly explore the introduction and academic evaluation of next-generation sequencing (NGS)–based oncology technologies across northern China. Prof. Wang Zhen – Senior Consultant of MagicBiotech (seated on the left), and Dr. Nguyen Hoai Nghia – Co-founder and CEO of Gene Solutions (seated on the right), signing MOU The collaboration will center on: Technical introduction of Gene Solutions' early cancer detection platforms for clinical and research exploration. Joint research activities with local institutions to assess technology performance, clinical utility, and future scalability within northern China's medical and academic frameworks. Development of a University–Hospital–Industry translational model, bridging innovation, real-world clinical validation, and data-driven optimization—aligned with institutional and regulatory standards. "Our partnership with MagicBiotech is a cornerstone for advancing precision oncology in China," said Ida Deleskog Lindstrom, Global Medical Affairs Director at Gene Solutions. "By fostering collaborative research and leveraging local expertise, we aim to validate and scale our technologies to meet the region's clinical and scientific needs." Driving Localized Innovation Through Strategic Collaboration These dual partnerships represent a calibrated approach by Gene Solutions to support the introduction and validation of advanced oncology diagnostics in China. Both collaborations are built on mutual strengths—balancing scientific rigor, ethical commercialization, and long-term research-driven engagement. Project-specific initiatives under each MOU will be rolled out progressively in alignment with local regulations and institutional priorities. About ZaoDx ZAODX Early Screening Network is a globally leading platform dedicated to the early detection of diseases, with a core mission to drive the transformation of global healthcare systems from treatment-centric models to a proactive, health-centered paradigm. Guided by the widely recognized principle that "prevention is the most cost-effective and impactful health strategy," ZAODX advocates the global adoption of early screening, early diagnosis, and early treatment — while also drawing inspiration from Traditional Chinese Medicine's wisdom of "treating disease before it occurs." As a truly international and multidisciplinary team, ZAODX brings together key stakeholders across the global healthcare ecosystem — including scientists, entrepreneurs, investors, policymakers, healthcare providers, and public health experts — united by the mission to make health screening accessible and equitable for all. The network has established strategic partnerships with over 1,000 top-tier medical institutions, academic organizations, professional societies, independent laboratories, and healthcare innovators to foster cross-border academic exchange, scientific collaboration, technology translation, industry synergy, and public health education. Committed to global public health goals, ZAODX actively supports initiatives led by the World Health Organization and national health authorities. Through collaborative efforts, ZAODX is building an innovative and inclusive early screening ecosystem — empowering the global fight for earlier prevention, better outcomes, and healthier populations worldwide. About Xiong'An MagicBiotech Xiong'An MagicBiotech is a biotechnology company in Xiongan New Area focusing on "in vitro diagnostic reagents + testing services + artificial intelligence". MagicBiotech is mainly engaged in independent research and development, production and sales of in vitro diagnostic kits for genetic testing. By using multi-omics medical examination data and bioinformatics AI artificial intelligence technology, it provides in vitro diagnostic reagents and medical testing services to medical institutions and patients; in the scientific research and technology service sector, MagicBiotech has always adhered to the concept of innovation-driven, continued to increase R&D investment, and made every effort to build a complete and advanced technology platform system. The system deeply covers cutting-edge fields such as genomics, proteomics, metabolomics, microbiome, and single-cell multi-omics. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. Explore more information at: https://genesolutions.com/
-
Safety Under Pressure: Chery Battery Faces Indonesian Ocean for 53+Hours - Still Running
JAKARTA, Indonesia, June 20, 2025 /PRNewswire/ -- On June 17, Chery commenced the second stage of its Global Safety Challenge in Jakarta, Indonesia, focusing on the "extreme humidity" scenario within its six-dimensional safety evaluation system (heat, cold, dryness, humidity, high-speed, and rough terrain). This rigorous test validated the moisture and corrosion resistance of the "Guardian Battery" in Chery Super Hybrid (CSH). Mr. Heri Prabowo, Head of the Sub-Directorate of Motor Vehicle Type Testing, Ministry of Transportation, and Mr. Christian Andersen, Notary, along with representatives from 80 leading media outlets and industry KOLs, attended the event to witness the battery's performance after 53 hours and 51 minutes of continuous saltwater soaking—demonstrating zero leakage, zero short circuit, and no signs of thermal runaway. The battery maintained structural integrity and passed all technical validations for electrical insulation. Once installed in the vehicle, it started successfully on the first attempt and delivered stable power throughout the road test, completing the rigorous challenge with zero anomalies. TIGGO8 CSH survives 53 hours and 51 minutes of continuous saltwater soaking CSH's "Guardian Battery" features IP68-rated waterproof and dustproof certification, an ultra-fast 2ms power cut-off response, an ultra-wide operating temperature range from -35°C to 60°C, and a 24/7 real-time health monitoring system—delivering comprehensive battery safety backed by advanced intelligent technologies. On the passive protection front, TIGGO8 CSH is equipped with a high-strength steel underbody shield with a tensile strength of 780 MPa, significantly enhancing the vehicle's overall safety performance. At the event, TIGGO8 CSH's spacious "5+2" seating layout and V2L ecosystem drew significant attention from guests. With the third-row seats folding flat at the touch of a button, the class-leading 1,930L trunk, paired with 36 storage compartments and a powerful 3.3 kW V2L system, TIGGO8 CSH provides a comfortable and enjoyable travel experience for the whole family on every journey. Committed to safety excellence, Chery continuously elevates technological innovation with user-centric engineering, benchmarking against industry leaders like Volvo through rigorous global safety challenges. As the second stage in Chery's global safety challenge, the Indonesian battery safety test in extreme humidity further validated the brand's safety technology. Looking ahead, Chery will conduct a rigorous underbody scraping test in the Mexican market to further evaluate the safety performance of CSH—highlighting Chery's commitment to delivering safer and more reliable mobility solutions to global customers. Photo - https://mma.prnasia.com/media2/2715360/1.jpg?p=medium600
-
The Department of Health - Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi
Reinforcing Abu Dhabi's position as a global life science hub ABU DHABI, UAE, June 20, 2025 /PRNewswire/ -- During BIO International Convention in Boston USA, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a landmark partnership to localise manufacturing of pharmaceuticals in Abu Dhabi and advance digital health solutions. Leveraging Abu Dhabi's advanced life sciences infrastructure, this milestone reflects the emirate's proactive preparedness to reduce dependency on imports, strengthen supply chain resilience, and foster a sustainable, self-sufficient healthcare ecosystem. The Department of Health – Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: "Following the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi, the emirate proved to be equipped with a holistic, integrated infrastructure that fosters local manufacturing and R&D, positioning it as a regional healthcare gateway and leader in life sciences. By integrating our strategic vision with Abbott's expertise, we aim to accelerate the development and deployment of innovative healthcare products and solutions, reducing time-to-market, improving healthcare outcomes, and ensuring that breakthrough therapies reach patients faster. This approach positions Abu Dhabi as a regional leader in fostering an agile, innovation-driven healthcare ecosystem that directly translates scientific advancements into tangible benefits for our community." The strategic collaboration outlines a comprehensive plan focusing on four key pillars including localisation of Abbott's pharmaceutical portfolio, biosimilar development, digital transformation through electronic patient information leaflets, and a robust education and workforce development initiative. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant said: "Abbott is proud to announce a strategic collaboration with the Department of Health – Abu Dhabi, aimed at advancing healthcare resilience and innovation in Abu Dhabi. Building on Abbott's long-standing commitment to the UAE's healthcare system, this partnership will focus on localising existing pharmaceutical products, and jointly exploring the development of biosimilars, supported by regulatory alignment. The collaboration also includes initiatives to digitise life science product information through electronic leaflets in alignment with the UAE's digital health strategy. Another key component of this collaboration is the development of education programs to build local capabilities. Additionally, Abbott and the Department of Health will evaluate opportunities for joint research and development to strengthen long-term healthcare sustainability in the UAE." Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 to 21, 2025. The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI).
-
Faraday Factory Japan signed an agreement to deliver superconductor tape for the demo stellarator magnet of Proxima Fusion
Proxima Fusion's first-of-a-kind power plant Stellaris will use high temperature superconductor magnets to confine the burning plasma TOKYO, June 20, 2025 /PRNewswire/ -- Proxima Fusion and Faraday Factory Japan have signed a contract for the supply of high temperature superconducting (HTS) tape. This delivery will help the leading European stellarator developer Proxima Fusion to achieve its next milestone – a superconducting demo magnet. Proxima Fusion’s first-of-a-kind power plant Stellaris will use high temperature superconductor magnets to confine the burning plasma Stellarators are fusion machines which contain hot, ionized matter (plasma) within a magnetic field of remarkable strength and sophisticated geometry. Significant progress including the highest plasma triple product sustained for tens of seconds was attained recently with the W7-X stellarator, which is built and operated by the Max Planck Institute of Plasma Physics (IPP) in Germany. Proxima Fusion, originally spun out from the IPP, is building on the record-breaking expertise of W7-X, combining it with advances in stellarator optimization, computational design and state-of-the-art HTS magnet technology. After completing delivering its demo magnet in 2027, Proxima will focus on the delivery of Alpha in 2031, Proxima's net-energy demo stellarator, followed by the first-of-a-kind commercial fusion power plant Stellaris in the 2030s. Timely supply of high-quality HTS tape is essential to keep fusion on fast track. While it takes thousands of kilometers of superconducting tape to build a typical energy-positive fusion prototype, scaling up the fusion industry to commercial power will require millions of kilometers. Since 2020, Faraday Factory has ramped up production by 10 times. The new HTS tape delivery contract is an important milestone, further strengthening the HTS supply chain for the nascent but transformative fusion industry.
-
AIA Singapore launches inaugural AIA Ultimate FitnessFest to champion healthier lifestyles
With support from HYROX, the AIA Ultimate FitnessFest is a pioneering hybrid fitness event dedicated to advocating healthy lifestyles and championing the need for individuals to be protected. SINGAPORE, June 20, 2025 /PRNewswire/ -- Leading health insurance provider AIA Singapore is proud to launch the inaugural AIA Ultimate FitnessFest (AUFF), with support from HYROX. Taking place throughout August, with the finale on 27 September 2025, AUFF features two thrilling editions — the University Edition and the Open Edition, catering to participants across all fitness levels. Building on AIA Singapore's ongoing partnership with HYROX for the AIA HYROX Open Asian Championships 2025[1], AUFF is the first-of-its-kind initiative that provides additional avenues for Gen Zs and people of all ages to "Rethink Healthy" — AIA's regional campaign that seeks to challenge stereotypes and narrow depictions of health in Asia and calls for new definitions of health that will encourage more people to live healthier. With only 2 in 5 (44%)[2] of Gen Zs in Singapore protected against personal accidents, raising awareness and providing access to financial protection for this under-insured group is crucial. AIA aims to champion the need to protect them by launching AIA #GenFit PA plan — an affordable personal accident plan designed to cover not just medical bills but also the active lifestyles of Gen Zs. They can reach out to an AIA consultant or insurance representative to learn more about the plan and the special AIA Vitality offer available with the purchase of AIA #GenFit PA plan in 2025. More information on the plan can be found here www.aia.com.sg/GenFit. "With rising healthcare costs in Singapore and a growing protection gap among Gen Zs, we are taking proactive steps to address this challenge," says Wong Sze Keed, Chief Executive Officer of AIA Singapore. "The AUFF University Edition, with support from HYROX, is more than just a fitness event — it's a meaningful platform to promote healthier, more active lifestyles while driving greater awareness of financial protection among younger Gen Zs. We hope to empower them to build a strong foundation for both physical and financial well-being as they work towards a more secure future." "Additionally, AIA Singapore is deepening our engagement with the community. The AUFF University Edition qualifiers at the finals on 27 September will have the exciting opportunity to compete against Team Strong Silvers, a group of senior citizens in Singapore who are known for challenging age stereotypes and promoting an active lifestyle among seniors in Singapore. Fitness is for everyone, and through AUFF, we want to encourage people of all ages to live healthier, longer, better lives." AUFF – University Edition Available to students from Singapore's local universities[3], the AUFF University Edition begins in August 2025 with the campus qualifiers, followed by the finals in September. The top two teams will win complimentary participation at the AIA HYROX Singapore race in November. The AUFF University Edition invites students to form teams of four and compete in qualifiers across Singapore. These qualifiers will test participants with challenges like rowing and synchronised weighted lunges. The top three teams from each university, based on their overall scores, will advance to the finals. The finals will feature a HYROX-inspired challenge, pushing teams through a high-intensity sequence designed to test their strength, endurance, and teamwork. The workout includes a 1,000-meter run, burpee broad jumps, walking lunges, a 1,000-meter row, hand-release push-ups, and finishes with an intense set of 100 wall balls. In the lead-up to the finals, each qualifying team will be encouraged to participate in the activities and earn bonus points which will be added to their scores at the finals. Designed to promote holistic well-being, these challenges encourage participants to Rethink Healthy through a variety of health-focused activities, including: Rainforest Amazing Race: Teams will race through the newly launched Rainforest Wild ASIA[4] at Mandai Wildlife Reserve's nature-filled, adventure-style challenge that strengthens bonds while reconnecting with the great outdoors. Run with AIA: Teams can organise runs with AIA to build camaraderie while enhancing their endurance and running techniques. Social and Charity: Participants can earn points by posting on their personal social media platforms around rallying supporters to attend the finals or raising awareness and funds for causes like AIA Better Lives Fund. HYROX Inspired Fitness Challenge: AIA HYROX's official gym partner, Fitness First, will be holding training sessions for teams to track their fitness progress. Rankings at these trainings will also earn them bonus points. AUFF – Open Edition The AUFF Open Edition is open to anyone curious about HYROX. Welcoming participants of all ages and fitness levels, it offers a "lite" version of the HYROX experience – designed to be accessible, fun, and inclusive. For more information on AIA Ultimate FitnessFest, visit www.aia.com.sg/ultimate-fitnessfest. About AIA AIA Group Limited and its subsidiaries (collectively "AIA" or the "Group") comprise the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets – wholly-owned branches and subsidiaries in Mainland China, Hong Kong SAR[5], Thailand, Singapore, Malaysia, Australia, Cambodia, Indonesia, Myanmar, New Zealand, the Philippines, South Korea, Sri Lanka, Taiwan (China), Vietnam, Brunei and Macau SAR[6], and a 49 per cent joint venture in India. In addition, AIA has a 24.99 per cent shareholding in China Post Life Insurance Co., Ltd. The business that is now AIA was first established in Shanghai more than a century ago in 1919. It is a market leader in Asia (ex-Japan) based on life insurance premiums and holds leading positions across the majority of its markets. It had total assets of US$305 billion as of 31 December 2024. AIA meets the long-term savings and protection needs of individuals by offering a range of products and services including life insurance, accident and health insurance and savings plans. The Group also provides employee benefits, credit life and pension services to corporate clients. Through an extensive network of agents, partners and employees across Asia, AIA serves the holders of more than 43 million individual policies and 16 million participating members of group insurance schemes. AIA Group Limited is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock codes "1299" for HKD counter and "81299" for RMB counter with American Depositary Receipts (Level 1) traded on the over-the-counter market under the ticker symbol "AAGIY". [1] 'AIA Singapore and HYROX Singapore team up to offer complimentary insurance at AIA HYROX Open Asian Championships 2025' March 20, 2025. Available at: https://www.aia.com.sg/en/about-aia/media-centre/press-releases/2025/aia-x-hyrox-open-asian-championships-2025 [2] The seventh wave of the AIA Live Better Study is an independent study that was conducted from 29 November to 9 December 2024 with a sample size of 1,000 representing Singapore's general population. [3] Participating universities include National University of Singapore (NUS), National Technological University (NTU), Singapore Management University (SMU), Singapore University of Social Sciences (SUSS), Singapore Institute of Technology (SIT) and Singapore University of Technology and Design (SUTD). [4] AIA Singapore has recently partnered with Mandai Wildlife Reserve on their newly opened Rainforest Wild ASIA as the naming sponsor of AIA Vitality Bounce and sponsor of the Tapir habitat. More information available here: https://www.aia.com.sg/en/about-aia/media-centre/press-releases/2025/aia-singapore-x-rainforest-wild-asia-tapir-adoption [5] Hong Kong SAR refers to the Hong Kong Special Administrative Region. [6] Macau SAR refers to the Macau Special Administrative Region.
-
HSG Laser Named India's Top Laser Equipment Brand for Third Consecutive Year, Strengthens Local Commitment at ACMEE 2025
CHENNAI, India, June 20, 2025 /PRNewswire/ -- At ACMEE 2025, one of South India's most prominent exhibitions for machine tools and automation, HSG Laser showcased a strong portfolio of smart manufacturing solutions. The company's presence reflects not only its technological strength but also its growing impact in the Indian market, where it has been ranked the No.1 laser equipment brand for three consecutive years (2023–2025). At Booth D18, HSG Laser showcased a trio of high-end laser systems designed to meet the demands of industrial manufacturers pursuing higher productivity, precision, and smart automation. G3015X: A high-power cutting solution built for heavy-duty mass production. With 140 m/min idle speed, 1.5G acceleration, and the AlphaT Plus control system, it ensures precise, efficient operation—ideal for automotive, machinery, and subcontracted fabrication. R2: A universal tube cutting machine supporting round, square, and irregular profiles up to 240 mm. Featuring intelligent nesting, short tailing, and automated handling, it's well-suited for furniture, fitness, and metal frame production in flexible batch sizes. C3015: A compact, cost-effective flatbed cutter with a space-saving open design, aluminum beam, and dual-servo drive. Tailored for startups, small workshops, and rapid prototyping, it delivers professional performance in limited spaces. Expanding Local Service Capabilities HSG Laser has been active in the Indian market since 2012, and its growth is underpinned by a long-term localization strategy. Today, 90% of its Indian team is composed of local professionals, reflecting the company's commitment to regional development and talent cultivation. In 2025, HSG has accelerated the expansion of its local service infrastructure, including: Spare Parts Warehousing: Enlarged regional parts centers to ensure faster delivery and reduce equipment downtime. After-Sales Service Centers: New service hubs established in key industrial zones to improve proximity and response times. Engineer Training Programs: Regular technical training for local engineers to ensure service consistency and up-to-date technical support. Multilingual Support & Localized Communication: Enhanced customer support systems that address regional language and cultural needs, ensuring smoother service interactions. "We see localization not just as a business strategy, but as a long-term responsibility," said a spokesperson for HSG's global operations. "Our goal is to empower customers through reliable technology, supported by fast, local service." Global Innovation, Local Execution HSG's presence at ACMEE 2025 marks another step in its global roadmap—delivering intelligent, efficient, and sustainable metalworking solutions tailored to local markets. As the company deepens its roots in India, it continues to balance world-class innovation with real-world customer needs, setting a benchmark for international players in the metal processing industry.
-
J&T Express Malaysia Achieves ISO 9001:2015 Certification, Setting New Standards in Quality Management
KUALA LUMPUR, Malaysia, June 20, 2025 /PRNewswire/ -- J&T Express Malaysia proudly announces its attainment of the ISO 9001:2015 certification, a prestigious recognition awarded for its commitment to quality management systems. This achievement reinforces the company's dedication to delivering exceptional services to its customers across Malaysia. The ISO 9001:2015 certification reflects J&T Express Malaysia’s ongoing commitment to operational excellence and quality management. ISO 9001:2015 is an internationally recognized standard that sets out criteria for a quality management system. This certification signifies J&T Express Malaysia's adherence to rigorous standards in its operational processes, customer service, and continuous improvement practices. "We are delighted to have received the ISO 9001:2015 Certification, as it reflects our unwavering commitment to providing top-tier services to our customers," said Jacky Hu, Public Affairs Manager, J&T Express Malaysia. "This achievement underscores our dedication to maintaining the highest standards of quality in every aspect of our operations." The ISO 9001:2015 Certification is a testament to J&T Express Malaysia's relentless pursuit of excellence and its focus on meeting and exceeding customer expectations. By adhering to these internationally recognized standards, the company aims to enhance customer satisfaction, improve operational efficiency, and drive continuous improvement across its entire service network. "We believe that this certification will further strengthen our position as a leading logistics provider in Malaysia," added Jacky Hu. "It demonstrates our commitment to quality, reliability, and excellence in all that we do." J&T Express Malaysia remains dedicated to upholding the highest standards of quality and service excellence as it continues to grow and evolve in the dynamic logistics industry. For more information about J&T Express Malaysia, please visit J&T Express Malaysia Official Website, Facebook and Instagram. About J&T Express J&T Express is a global logistics service provider with leading express delivery businesses in Southeast Asia and China, the largest and fastest-growing market in the world. Founded in 2015, J&T Express' network spans thirteen countries, including Indonesia, Vietnam, Malaysia, the Philippines, Thailand, Cambodia, Singapore, China, Saudi Arabia, the UAE, Mexico, Brazil and Egypt. Adhering to its "customer-oriented and efficiency-based" mission, J&T Express is committed to providing customers with integrated logistics solutions through intelligent infrastructure and digital logistics network, as part of its global strategy to connect the world with greater efficiency and bring logistical benefits to all.
-
LPS and QAX Announce Strategic Partnership for Cybersecurity, Unveiling Security Operation Centre and End-to-End Security Services
The duo's first joint Security Operation Centre (SOC) in Hong Kong addresses the urgent need for advanced cybersecurity defenses amidst surging cyber threats. The new SOC harnesses LPS' decades of managed services leadership and QAX's stellar cybersecurity track record to fortify enterprises with cyber threat protection. HONG KONG, June 20, 2025 /PRNewswire/ -- Lenovo PCCW Solutions (LPS) announces the launch of the first Security Operation Centre (SOC) in collaboration with leading Chinese cybersecurity firm, Qi An Xin Technology Group (QAX), aiming to address a critical market need for end-to-end managed security operation services to combat increasingly complex cyber threats. Powered by QAX's advanced threat detection and prevention technologies, as well as its global threat intelligence capabilities, alongside LPS' industry leading managed services, the SOC is located in Hong Kong and offers 24/7 security operation services. The SOC will empower enterprises to embrace AI technologies while ensuring compliance and fortified protection. The Asia-Pacific region is a major hotspot for cyberattacks due to the rapid proliferation of digital technology, with the largest recorded data breach to date costing up to USD 20 million[1]. Hong Kong experienced a similarly alarming trend in 2025, as the Hong Kong Computer Emergency Response Team Coordination Centre (HKCERT) reported a 67%[2] year-on-year increase in cybersecurity incidents during the first quarter alone. The city's regulatory framework has been growing in response, with standards like the Protection on Critical Infrastructures (Computer Systems) Bill, the Insurance Authority's revised Guideline on Cybersecurity (GL20), and the updated Government IT Security Guideline (G3) requiring organizations to strengthen cybersecurity defences, enhance employee awareness, and align with compliance frameworks to mitigate risks. The strategic partnership integrates advanced AI-powered threat detection with human expertise to deliver comprehensive cybersecurity protection for enterprises. Key features include offensive and defensive security services, along with a security dashboard that visually presents vulnerabilities, attacker behavior, and overall risk levels – enabling enterprises to better understand and manage their security risk. LPS' expertise in Hong Kong's IT ecosystem and unique cross-industry knowledge will be an invaluable asset for enterprises faced with the unique challenges of the dynamic cybersecurity landscape. "With the accelerating pace of digital transformation and the rise of cyber threats, the demand for secure and resilient digital ecosystems is greater than ever before. Our SOC will address the critical need for advanced cybersecurity solutions." said Dr. Ted Suen, President of LPS, further elaborating that, "LPS is committed to collaborating with cybersecurity leaders like QAX to integrate advanced emerging technologies, actionable threat intelligence, and extensive industry expertise into our security offerings, empowering enterprises to navigate the digital age with safety and confidence." Meanwhile, QAX boasts a proven track record of defending against high-profile cyberattacks – including at the 2022 Beijing Winter Olympics where they successfully achieved zero incidents. QAX's cybersecurity specialists also possess comprehensive capabilities for mitigating security risks in large language models (LLM), providing enterprises with enhanced protection through their proprietary LLM security solution. Qi Xiangdong, Chairman of QAX Group, said: "Our partnership with LPS to launch the first SOC in Hong Kong reflects our shared dedication to protect clients' valuable assets and data. QAX will work together with partners, leveraging proprietary technologies and years of accumulated expertise in safeguarding national projects to advance the implementation of cybersecurity technologies, enhance localized operations and service capabilities, and provide enterprises with robust tools to navigate an increasingly complex and dynamic threat landscape." The establishment of the SOC heralds a new era for cybersecurity in Hong Kong, offering a comprehensive, 24/7 shield against cyber threats. LPS will continue to enhance its security services as a trusted digital advisor and look to build on this milestone partnership with QAX to drive secure growth and digital transformation for clients across the Asia Pacific region. At the launch of the Security Operation Centre at LPS' Hong Kong headquarters, Jimmy Tsang, Head of Technical Infrastructure Services of LPS (left), and Howard Lv, Partner and Vice President of QAX Group (right), celebrate this milestone partnership aimed at safeguarding enterprises’ digital futures. About Lenovo PCCW Solutions (LPS) LPS is a leading IT and technology solutions provider in the Asia Pacific region. We partner with governments and enterprises to achieve digital transformation excellence, driving business growth through our market-leading solutions and industry best practices. As a proud member of Lenovo Group, we have unlocked new synergies with Lenovo's global reach and technological capabilities, focusing on AI, data practice, cloud and cybersecurity. With our 4,000+ team of domain experts and a strong network of ecosystem partners, LPS is committed to providing cutting-edge AI-powered solutions and data best practices to enable organizations to excel in their digital journey. About QAX Technology Group QAX is the largest cybersecurity company based in China, and a leader in cybersecurity industry, providing new generation enterprise - level and national - level cybersecurity solutions. Years of R&D and innovation accumulated from cyber offense and defence practice, QAX has reinforced the strength in big data, AI, machine learning and security operation. As the official cybersecurity services and anti - virus software sponsor of the Olympic and Paralympic Winter Games Beijing 2022, QAX successfully secured the Olympic - Games with zero - cyber incident. [1] Source: 2024 Global Digital Trust Insights, PwC [2] Source: Hong Kong Security Watch Report (Q1 2025), HKCERT
-
New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure
Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20, 2025 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures at the ISAPS Olympiad World Congress in Singapore, showing more than 17.4 million procedures performed by plastic surgeons and 20.5 non-surgical procedures. Over the last four years, the overall increase is 42.5%. ISAPS Global Survey Aesthetic Procedures Eyelid surgery, for the first time, was the most common surgical procedure in 2024, replacing liposuction, with 2.1 million, followed by liposuction, breast augmentation, scar revision, and rhinoplasty. The most popular non-surgical procedures were botulinum toxin, hyaluronic acid (filler), hair removal, non-surgical skin tightening, and chemical peels. Most face and head procedures showed growth from the previous year, with more than 7.4 million procedures and a 4.3% increase. Top procedures were eyelid surgery with more than 2.1 million and a 13.4% increase, rhinoplasty with 1 million procedures and a 10% decrease, and fat grafting – face 0.9 million and a 19.2% increase. There were 3.9 million breast procedures (-14.1%) and 6 million body and extremities procedures (-14.8%). Liposuction was still the most common surgical procedure for women, followed by eyelid surgery and breast augmentation. Eyelid surgery was again the most popular surgical procedure among men, followed by gynecomastia and scar revision. Most breast augmentations (54% of the total), rhinoplasties (60.1%), and external genital surgery (48.4%) took place on 18–34-year-olds, whereas botulinum toxin injectables were most popular among those aged 35–50 (47.0% of the total). Liposuction and non-surgical fat reduction were distributed quite evenly among both age groups. Botulinum toxin remained the most common non-surgical procedure for both men and women and among all age groups, with 7.8 million procedures performed by plastic surgeons worldwide. In second place, hyaluronic acid procedures increased by 5.2% to 7.8 million. Commenting on the global results, Dr. Amin Kalaaji, Chair of the ISAPS Global Survey Committee and plastic surgeon in Norway, said, "Our report now includes data on 'Mommy Makeover' and other combined procedures, scar revision, hand rejuvenation with fat grafting, buccal fat removal, inverted nipple correction, dimple creation, and other outer genital surgery." Once again, the US performed the most procedures with over 6.1 million, followed by Brazil with 3.1 million (which is first in surgical procedures), and Japan. For media inquiries, please contact media@isaps.org.
-
Cochlear celebrates 30 Years in China and the launch of the world's first and only smart hearing implant system
The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable firmware.1+ This year marks the 30-year anniversary since the first adult cochlear implant surgery in mainland China which took place in 1995. Nearly 10 million people in China are suffering from severe to profound hearing loss, among whom only 1% are treated with cochlear implant. BOAO, China, June 20, 2025 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa™ System – the world's first and only smart cochlear implant system.1+ Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of research and development advancements built into the new Nucleus Nexa System. The System is powered by the new state-of-the-art chipset - the first update to any implant's internal chipset across the cochlear implant industry in almost 20 years. The new chipset utilises advanced processing, upgradeable firmware and onboard memory to drive the 'smarts' of the system and allows the implant to do many things that conventional cochlear implants are simply unable to do. This latest release represents a significant step forward in technology not just in our industry but importantly for people in China living with hearing loss." jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2715321/video_20.mp4', image: 'https://mma.prnasia.com/media2/2715321/video_20.mp4?p=medium', autostart:'false', stretching : 'uniform', width: '512', height: '288'}); "We estimate there are tens of millions of people in China who could benefit from a cochlear implant. Thirty years since the very first cochlear implant surgery in China took place, we are incredibly proud to offer the new Nexa System in the Boao Lecheng International Medical Tourism Pilot Zone. We hope the Bo'ao pilot zone can be the door for Chinese people with hearing loss to access the latest product with innovative technology. In addition, we hope this accelerates the new product approval in the mainland market through the clinical evidence collection and professional capability development in the pilot zone," added Mr Li. The groundbreaking Nucleus Nexa System offers the world's first hearing implant solution with upgradeable implant firmware, revolutionising the way people with hearing loss can access future technology. 1+ Conventional cochlear implants available today can only access future innovation by upgrading their sound processor. With the Nucleus Nexa System this limitation is removed. People with a Nucleus Nexa System will be able to experience new features and advancements, via both updates to the firmware in their smart implant and upgrades to their sound processor over time. Jan Janssen, Chief Technology Officer at Cochlear, likens the Nucleus Nexa Implant to a smartphone for hearing: "This is the first cochlear implant in the world with its own firmware, meaning users can upgrade to new features and innovations throughout their lifetime. Just like a smartphone receives a firmware update, now people with a cochlear implant can stay connected to the latest technology updates seamlessly today and well into the future." The Nucleus® Nexa™ System is the also the first implant with built-in memory, allowing the personalised hearing settings (MAPs) of the user to be securely stored directly in their Nexa implant.[1] This innovation ensures users can seamlessly transfer their settings to a new Nucleus Nexa Sound Processor if their current one is lost or damaged. "The Nucleus Nexa System comes with a distinct advantage – it is the world's first cochlear implant with built-in memory, allowing user's personalised hearing settings (MAPS) to be stored securely in the implant. This advancement brings a greater level of personalisation to the hearing implant and offers unmatched convenience and efficiency." "Previously, if a user misplaced or damaged their sound processor, they would need to visit a clinic to obtain a replacement sound processor. This replacement device would need to be programmed with the user's personalised hearing settings in the clinic by a cochlear implant professional, taking valuable time from both the professional and the user. With the brand-new 'Smart Sync' feature, the user simply needs to pick-up or receive a "blank" Nexa sound processor and the personalised settings are automatically copied to the replacement sound processor allowing a person to hear with their cochlear implant again in a matter of seconds," explained Janssen. To make hearing easier, the Nucleus Nexa System intuitively responds to changing needs throughout each day.[1, 3-5] It can automatically adjust listening settings to help people hear more clearly.[1] The Nexa implant also features a new gold coil and new RF Link technology with dynamic power management. This facilitates more efficient power and data transfer between the sound processor and the implant and automatically maximize battery life for each user.# Stu Sayers, President of Asia Pacific & Latin America at Cochlear, explained the introduction of the Nexa System is timely given it coincides with a significant milestone for the business: "We have a proud history in China, and it is fitting that in 2025, the year we celebrate 30 years since the first cochlear implant surgery in China, we are introducing this next generation technology. Our innovative mindset and lifetime commitment to the thousands of people in China and around the world who rely on our products to hear is what sets us apart. We continue to break new ground with our products and services, driven by our passion to make a remarkable impact on the lives of people living with hearing loss." "The Nucleus Nexa System combines 40+ years of proven reliability of our trusted implants and technology leadership, with the new cutting-edge chipset packed with innovative features. With onboard diagnostics that monitor system performance to ensure optimal hearing, it reduces the burden on users and carers, setting a new standard in implantable hearing technology," added Mr Janssen. Cochlear has provided more than 850,000 hearing implants to people around the world and the company's implants have a proven track record of reliability over 40 years which is one of many reasons people choose a Cochlear hearing solution more than any other brand.[6-7] In 2024 Cochlear was named the number one most trustworthy company in the healthcare industry by Newsweek in its rankings of the World's Most Trustworthy Companies. This prestigious recognition underscores Cochlear's unwavering commitment to excellence, innovation, and customer-centricity. - Ends - Commercial availability: The new Cochlear™ Nucleus® Nexa™ System will be available in the Boao Lecheng International Medical Tourism Pilot Zone from 20 June 2025 and it will be available in Hong Kong from 16 June 2025. About hearing loss in China According to the World Health Organization (WHO), hearing loss is a major public health issue in China, and its prevalence is expected to increase. The Chinese government has been vigorously promoting the prevention and treatment of hearing loss by establishing and constantly improving the management, technical guidance, and service systems.[2] However, many people with hearing loss still do not seek or receive hearing health care.[2] More than 95 million people in China had moderate-to-complete hearing loss in 2019 according to health estimates.[2] Approximately two in five Chinese people will have hearing loss by 2034 according to health estimate projections.[2] More than 17,000 were born with hearing loss in 2020 according to China CDC data.[8] The Bo'ao Pilot Zones represent critical platforms for Cochlear to introduce cutting-edge hearing solutions, conduct real-world research, and support the development of China's healthcare industry. By aligning with the policies and objectives of these zones, Cochlear remains committed to enhancing the lives of Chinese patients and contributing to the nation's progress in healthcare innovation. About Cochlear Implants Unlike hearing aids which increase the volume of sound, cochlear implants work by enhancing sound clarity, bypassing the damaged part of the ear entirely to stimulate the hearing nerve directly. Cochlear implants focus on enhancing clarity of sound, while hearing aids mostly work by making sounds louder.[9-11] This clarity could help people reclaim their confidence and fully immerse themselves in the meaningful moments of everyday life. About the Cochlear™ Nucleus® Nexa™ System The new system includes the Nucleus Nexa Implant, the Nucleus Kanso® 3 Nexa Sound Processor and the Nucleus 8 Nexa Sound Processor. The Nucleus Nexa Implant and sound processors are supported by Nucleus SmartNav, Nucleus Smart App, Custom Sound® Pro fitting software and wireless accessories. The new Nucleus® Nexa™ System can learn about its user's listening needs and the environment they are in. It can then automatically adjust listening or power management settings to help people hear more clearly[1] or maximise battery life.#* Users can enjoy clearer sound streamed directly from compatible* mobile devices and, in the future, at airports, concert venues and more using Bluetooth® LE Audio and Auracast™ broadcast audio.¥ About Cochlear Limited (ASX: COH) People have always been Cochlear's inspiration, ever since Professor Graeme Clark set out to create the first multi-channel cochlear implant after seeing his father struggle with hearing loss. Since 1981, Cochlear has helped more than 700,000 people in more than 180 countries to hear. As the global leader in implantable hearing solutions, Cochlear connects people with life's opportunities, and welcomes them to the world's largest hearing implant community. Cochlear has a global workforce of more than 5,000 people, with a passion for progress, who strive to meet the needs of people living with hearing loss. The company continually innovates to anticipate future needs, investing more than AUD$3 billion to date in research and development to push the boundaries of technology and help more people hear. www.cochlear.com References and disclaimers Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information. Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology. D1509691 CI1000 Implant Product Specification. Cochlear Limited; 2023 Aug. H. Wang, Y. Chen, Z. Yang, L. Zhu, Y. Zhao, T. Tian. Estimation and projection of the burden of hearing loss in China: findings from the Global Burden of Disease Study 2019. Public Health, Volume 228, March 2024, Pages 119-127. Published online 13 February 2024. Available at: https://doi.org/10.1016/j.puhe.2024.01.004 Mauger SJ, Warren CD, Knight MR, Goorevich M, Nel E. Clinical evaluation of the Nucleus®6 cochlear implant system: Performance improvements with SmartSound iQ. International Journal of Audiology. 2014 Jul 9;53(8):564–76. Mauger SJ, Jones M, Nel E, Janine Del Dot. Clinical outcomes with the KansoTM off-the-ear cochlear implant sound processor. International Journal of Audiology. 2017 Jan 9;56(4):267–76. Wolfe J, Neumann S, Marsh M, Schafer E, Lianos L, Gilden J, et al. Benefits of Adaptive Signal Processing in a Commercially Available Cochlear Implant Sound Processor. Otology & Neurotology. 2015 Aug;36(7):1181–90. D2182827 Cochlear Nucleus Reliability Report. Cochlear Limited; 2023 Dec. Cochlear. Annual reports [Internet]. Cochlear. 2021. Available from: https://www.cochlear.com/au/en/corporate/investors/annual-reports Zhili Wang, Yunge Gao, Yuzhang Huang, Wenying Nie, Yun Li, Haibin Sheng, Jie Chen, Yuzhu Guo, Kun Han, Zhiwu Huang, Fan Jiang, Jun Zhang, Hao Wu, Ying Chen. Implementation of Universal Newborn Hearing Screening and Analysis of School Enrollment Among Hearing-Impaired Students in China[J]. China CDC Weekly, 2025, 7(9): 312-317. doi: 10.46234/ccdcw2025.050 Fitzpatrick EM, Leblanc S. Exploring the Factors Influencing Discontinued Hearing Aid Use in Patients With Unilateral Cochlear Implants. Trends in Amplification [Internet]. 2010 Dec 1 [cited 2020 Jul 4];14(4):199–210. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111407/ Rumeau C, Frère J, Montaut-Verient B, Lion A, Gauchard G, Parietti-Winkler C. Quality of life and audiologic performance through the ability to phone of cochlear implant users. European Archives of Oto-Rhino-Laryngology. 2014 Dec 20;272(12):3685–92. Runge CL, Henion K, Tarima S, Beiter A, Zwolan TA. Clinical Outcomes of the CochlearTM Nucleus® 5 Cochlear Implant System and SmartSoundTM 2 Signal Processing. Journal of the American Academy of Audiology. 2016 Jun 1;27(6):425–40. ± Smart cochlear implant system is defined as the first and only cochlear implant having Internal memory with upgradeable firmware. # Battery life varies for every user, according to the age of the battery, the programs used each day, your implant type, the thickness of skin covering your implant, and the size and type of battery used. Streaming from compatible devices, True Wireless Devices or FM may decrease sound processor battery life depending on how often and for how long streaming is engaged. * The Cochlear Nucleus 8 Nexa and Nucleus Kanso 3 Nexa sound processors are compatible with Apple and Android devices. For compatibility information and devices visit www.cochlear.com/compatibility ¥ As Bluetooth LE Audio compatible devices become available, a firmware update will be required for you to use certain features. Auracast™ broadcast audio capability is subject to third party adoption of the Auracast protocol. The Bluetooth® and Auracast™ word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Cochlear Limited is under license.
-
Ottai Unveils Revolutionary AI-Powered Biosensor Set to Transform Chronic Disease Care
Groundbreaking Technology Empowers Patients to Take Control of Their Health HONG KONG, June 20, 2025 /PRNewswire/ -- Ottai, an Oxford-originated pioneer in AI digital health innovation, today announced the launch of its next-generation AI-powered wearable designed to revolutionize chronic disease management. This breakthrough device continuously monitors key biomarkers, leverages AI for real-time analysis and health log input, enhances patient-device interaction, and delivers personalized lifestyle recommendations. The Ottai biosensor disrupts the paradigm of traditional chronic disease monitoring—characterized by manual input, periodic lab tests, and reactive symptom management—by offering continuous monitoring paired with AI-driven automated and personalized inputs. It integrates deep learning algorithms to analyze vast amounts of real-time biomarker data and health logs, delivering actionable, tailored recommendations. The biosensor also supports intuitive voice-activated commands, allowing users to ask questions and add inputs while receiving real-time, personalized advice. "The Ottai biosensor represents a critical step toward scalable, patient-centric care," said Dr. Calvin Wang, Research Scientist at Ottai. "It represents a new era in healthcare—where we combine biosensing with AI to provide a dynamic and adaptive tool that evolves with patients' health needs and supports long-term disease management." Ottai's biosensor integrates with an AI-powered app to provide real-time glucose monitoring and personalized health insights, empowering users to manage their diabetes effectively. The biosensor uses AI to power a smart health companion that supports users in real time: Real-Time Biomarker Analysis: Track critical health metrics like glucose and detect episodes of hyperglycemia and hypoglycemia continuously. The device is validated against medical gold standards and CE-approved for its accuracy and reliability. Personalized Recommendations: AI algorithms process data to suggest lifestyle, dietary, and activity adjustments, optimizing long-term health outcomes. Voice-Activated Health Logs and Lifestyle Inquiries: Interact with the biosensor via voice commands to effortlessly log health data, dietary and lifestyle habits, personalized questions, receiving real-time, actionable responses. AI-Driven Data Analysis: Advanced machine learning algorithms to analyze complex datasets, that offers users real-time insights into their health trends and risks. Seamless Integration with Other Health Apps: Syncs with other health-tracking platforms such as Apple Health and smartwatches for users' best convenience. About Ottai Ottai is a leader in empowering individuals with actionable insights to prevent and manage chronic conditions. With a mission to make chronic disease management more accessible, personalized, and proactive, Ottai aims to revolutionize the healthcare landscape with advanced, user-friendly solutions. For more information and pricing and availability of Ottai sensors, visit www.ottai.com or contact info@ottai.com , and connect with Ottai on Instagram , and Facebook .
-
SAINT-GOBAIN ENHANCES ITS DIGITAL CONSTRUCTION CHEMICALS PLATFORM WITH THE ACQUISITION OF MATURIX
PARIS, June 20, 2025 /PRNewswire/ -- Saint-Gobain announces the next step in the expansion of its digital construction chemicals platform with the acquisition of Maturix, based in Denmark, a leading provider of real-time monitoring solutions for the concrete industry. Saint-Gobain acquires Maturix, cementing its leadership in construction tech Maturix offers cutting-edge wireless sensor technology which allows remote real-time monitoring of concrete properties during the curing and hardening process, enabling contractors to optimize their operations and ease traceability requirements. This reduces the duration of the concrete construction cycle by up to 50% and improves job-site efficiency, all while improving concrete quality and ensuring a high level of structural performance. Maturix and Saint-Gobain have successfully collaborated since 2019. This acquisition enhances Saint-Gobain's digital solutions offering across the concrete and cement value chains, enabling the Group's customers to reduce overdesign and optimize operations. Saint-Gobain spearheaded the digital transformation of the concrete industry initiated by GCP with Verifi®, its market-leading digital in-transit concrete management suite, deployed across three continents (North America, Europe, and Asia-Pacific). Verifi® uses real-time monitoring to reduce waste, improve operational performance and drive cost efficiencies. Maturix perfectly complements Verifi® in optimizing concrete placement on site. The two companies are already working on a joint offering. The acquisition of Maturix demonstrates the Group's commitment to expanding its offer of integrated digital solutions for its customers. Sid Singh, CEO of Verifi®, comments: "By combining the data and digital expertise of Maturix and Verifi® with Saint-Gobain's leadership in concrete admixtures, we will unlock new use cases for the Group's customers. We will provide them with personalized recommendations to manage their operations with increased visibility and precision to reduce their costs and environmental impact." About Saint-Gobain Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME". - €46.6 billion in sales in 2024 - More than 161,000 employees, locations in 80 countries - Committed to achieving net zero carbon emissions by 2050 For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain Contacts: Patricia Marie - patricia.marie@saint-gobain.com Laure Bencheikh - laure.bencheikh@saint-gobain.com Yanice Biyogo - yanice.biyogo@saint-gobain.com Saint-Gobain acquires Maturix, cementing its leadership in construction tech
-
FinVolution Group Announces Proposed Offering of US$130 Million Convertible Senior Notes
SHANGHAI, June 20, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution" or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines, today announced a proposed offering (the "Notes Offering") of convertible senior notes in an aggregate principal amount of US$130 million due 2030 (the "Notes"), subject to market conditions and other factors, only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company intends to grant the initial purchasers in the Notes Offering an option to purchase up to an additional US$20 million in aggregate principal amount of the Notes, exercisable for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued. The Company plans to use the net proceeds from the Notes Offering for (i) international business expansions, (ii) replenishment of working capital, and (iii) funding the Concurrent Repurchase (as described below). Proposed Terms of the Notes When issued, the Notes will be senior, unsecured obligations of the Company. The Notes will mature on July 1, 2030 unless repurchased, redeemed, or converted in accordance with their terms prior to such date. Holders may convert their Notes at their option at any time prior to the close of business on the third scheduled trading day immediately preceding the maturity date. Upon conversion, the Company will pay or deliver, as the case may be, cash, ADSs, each representing five Class A ordinary shares of the Company, or a combination of cash and ADSs, at the Company's election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Notes Offering. Holders of the Notes may require the Company to repurchase all or part of their Notes for cash on July 3, 2028 or in the event of certain fundamental changes, in each case, at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the relevant repurchase date. Furthermore, the Company may redeem all but not part of the Notes in the event of certain changes in the tax laws or if less than 10% of the aggregate principal amount of the Notes originally issued remains outstanding at such time, in each case, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the related redemption date. Any redemption may occur only prior to the 92nd scheduled trading day immediately preceding the maturity date. Concurrent Repurchase Concurrently with the pricing of the Notes Offering, the Company plans to repurchase a number of ADSs to be determined at the time of pricing of the Notes Offering from certain purchasers of the Notes in off-market privately negotiated transactions effected through one of the initial purchasers or its affiliates, as the Company's agent (such transactions, the "Concurrent Repurchase"). The Concurrent Repurchase is expected to facilitate the initial hedging by purchasers of the Notes who desire to hedge their investments in the Notes, as the Company intends to repurchase the entire initial delta of the transaction. This will allow such purchasers of the Notes to establish short positions that generally correspond to commercially reasonable initial hedges of their investments in the Notes. The Concurrent Repurchase will be made pursuant to the Company's existing share repurchase programs announced in August 2023 and March 2025. The Company expects the purchase price in the Concurrent Repurchase to be the last reported sale price per ADS on the New York Stock Exchange on June 18, 2025. Other Matters The repurchase activities by the Company in the Concurrent Repurchase could increase, or reduce the magnitude of any decrease in, the market price of the ADSs and/or the trading price of the Notes. The Company expects that potential purchasers of the Notes may employ a convertible arbitrage strategy to hedge their exposure in connection with the Notes. Any such activities by potential purchasers of the Notes following the pricing of the Notes Offering and prior to the maturity date could affect the market price of the ADSs and/or the trading price of the Notes. The effect, if any, of the activities described in this paragraph, including the direction or magnitude, on the market price of the ADSs and/or the trading price of the Notes will depend on a variety of factors, including market conditions, and cannot be ascertained at this time. The Notes, the ADSs deliverable upon conversion of the Notes, if any, and the Class A ordinary shares represented thereby have not been and will not be registered under the Securities Act, or any securities laws of any other places. They may not be offered or sold within the United States or to U.S. persons, except to persons reasonably believed to be qualified institutional buyers in reliance on the exemption from registration provided by Rule 144A under the Securities Act. This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any securities, nor shall there be a sale of the securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This press release contains information about the pending Notes Offering, and there can be no assurance that the Notes Offering will be completed. About FinVolution Group FinVolution Group is a leading fintech platform with strong brand recognition in China, Indonesia and the Philippines, connecting borrowers of the young generation with financial institutions. Established in 2007, the Company is a pioneer in China's online consumer finance industry and has developed innovative technologies and has accumulated in-depth experience in the core areas of credit risk assessment, fraud detection, big data and artificial intelligence. The Company's platforms, empowered by proprietary cutting-edge technologies, features a highly automated loan transaction process, which enables a superior user experience. As of March 31, 2025, the Company had 216.2 million cumulative registered users across China, Indonesia and the Philippines. For more information, please visit https://ir.finvgroup.com. Safe Harbor Statement This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company's ability to attract and retain borrowers and investors on its marketplace, its ability to increase volume of loans facilitated through the Company's marketplace, its ability to introduce new loan products and platform enhancements, its ability to compete effectively, laws, regulations and governmental policies relating to the online consumer finance industry in China, general economic conditions in China, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the NYSE, including its ability to cure any non-compliance with the NYSE's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and FinVolution does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law. For investor and media inquiries, please contact: In China: FinVolution GroupHead of Capital MarketsYam ChengTel: +86 (21) 8030-3200 Ext. 8601E-mail: ir@xinye.com Piacente Financial CommunicationsJenny CaiTel: +86 (10) 6508-0677E-mail: finv@tpg-ir.com In the United States: Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050E-mail: finv@tpg-ir.com
-
Aussie Families Paying the Winter Flu Penalty: New Data Reveals the Costly Impact of Cold and Flu on Households
As Australian families grapple with rising living costs, new research reveals the toll of winter cold and flu on household finances, as well as family health and wellbeing. SYDNEY, June 20, 2025 /PRNewswire/ -- New research released reveals the majority (86%) of Aussie families are facing extra expenses each cold and flu season, with 42% reportedly spending between $100-$300 on cold and flu-related healthcare alone. With weekly groceries estimated at $213.64 per family, the winter season is not only taking a toll on health but also placing significant pressure on household budgets. Findings from the Winter (Un)Wellness survey commissioned by FESS® reveal it's not just the cost of healthcare items and services that are taking a toll on family's finances. Half (51%) of Aussie parents have had to take time off work due to falling ill with a cold or flu themselves, with almost 1 in 4 (24%) needing to take more than three days off in the past year. Sick days, potential loss of income, and often unexpected healthcare costs make the cold and flu season tough on families as the cost of living continues to rise. The data shows young Aussie families are being hit hardest by the winter flu penalty with a staggering 80% of those with kids aged 0–5 and 79% of parents with school-aged children, have taken time off work to care for sick children. The data also reveals that almost three-quarters (74%) of parents with children aged 0-5 years are spending more on their groceries due to sickness, with a quarter (26%) of those families spending significantlymore than they usually would. Dr Jonny Taitz, specialist general paediatrician said, "As a paediatrician, I see firsthand how tough the winter months can be on families - not just physically, but financially too. When young children fall sick, parents are often forced to take time off work, manage sleepless nights, and juggle added healthcare costs, all while trying to keep their households running. The Winter (Un)Wellness survey highlights what many families already feel every winter - that cold and flu season doesn't just hit hard, it hits the hip pocket as well." While the majority (69%) of Aussie families have been vaccinated to help protect their household during cold and flu season, access to cold and flu related healthcare remains a challenge. Over a third (39%) of Aussie parents cite long wait times at GP clinics as a major barrier and 38% point to a lack of bulk-billed services as a key obstacle to seeking care for troublesome symptoms. At the first sign of illness, the top essential items chosen by Aussie families to help combat the onset of cold and flu symptoms at home are pain and fever relief (50%), vitamins (25%) and nasal spray (14%). The cold and flu season has considerable impacts on families' overall wellbeing, particularly when it comes to their daily routines and activities. While quality sleep is essential for families, disrupted sleep is reported as the number one impact of coming down with a cold or flu. Physical discomfort was cited as the worst part of being home sick, highlighting how essential good health is for parents - who not only need to feel well enough to care for their children, but also find it difficult to watch their little ones suffer through cold and flu symptoms. "Access to care remains a real concern, long wait times and the decline in bulk-billed services are making it harder for parents to get the help they need when their child falls sick. That's why its important families feel confident managing mild symptoms at home. Essentials like pain and fever relief, vitamins, and nasal spray, especially saline-based options, or even sinus washes for young children can help early symptom management and make a big difference. Alongside rest, fluids, and good hygiene, these simple steps can support recovery and help ease the strain on both kids and parents" said Dr Jonny Taitz.
